Physician

Patrick Dreyer, DO

According to 2025 Medicare claims, Patrick Dreyer, DO (NPI: 1497127054) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55435-2281. Dreyer is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Dreyer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 108,667 HCPCS/CPT codes, and received $2,095,641 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,502 prescription claims across 259 beneficiaries totaling $3,376,035 in drug costs, led by Revlimid (Lenalidomide). Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $364 to $3,376,035. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.1M2021 Medicare payment: $379,547 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $974,040 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,259,494 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,095,641 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202116133,999$379,547
202236792,508$974,040
2023418113,824$1,259,494
2024436108,667$2,095,641

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.4M2017 Drug cost: $364 (USD; Tot_Drug_Cst)2018 Drug cost: $3,418 (USD; Tot_Drug_Cst)2019 Drug cost: $74,334 (USD; Tot_Drug_Cst)2020 Drug cost: $302,453 (USD; Tot_Drug_Cst)2021 Drug cost: $207,927 (USD; Tot_Drug_Cst)2022 Drug cost: $1,247,176 (USD; Tot_Drug_Cst)2023 Drug cost: $2,134,987 (USD; Tot_Drug_Cst)2024 Drug cost: $3,376,035 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R26$364
20181527$3,418
20191686$74,334
2020N/R83$302,453
202149159$207,927
2022158630$1,247,176
20232271,089$2,134,987
20242591,502$3,376,035

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more214476$90
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's80107$12
80053Blood test, comprehensive group of blood chemicals159359$10
36415Insertion of needle into vein for collection of blood sample186479$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count194541$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide501,362$776,177
OjjaaraMomelotinib Dihydrochloride16480$404,653
TagrissoOsimertinib Mesylate25750$396,529
CabometyxCabozantinib S-Malate15570$374,564
CalquenceAcalabrutinib Maleate14420$205,853

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$16E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Patrick Dreyer, DO?

Tedicare shows public-source Medicare data for Patrick Dreyer, DO (NPI 1497127054), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick Dreyer, DO have ACO affiliation data?

Patrick Dreyer, DO is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Patrick Dreyer, DO?

Patrick Dreyer, DO is linked to MINNESOTA ONCOLOGY HEMATOLOGY, PA (billing NPI 1528035995) in the available physician profile data.

Does Patrick Dreyer, DO have Open Payments data?

Patrick Dreyer, DO has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.